Tariman, Zairen Audrey .
HRN: 23-84-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2023
CEFUROXIME 750MG (VIAL)
10/04/2023
10/10/2023
IVF
470mg
Q8hrs
URTI; UTI With Mod Dhn
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes